Literature DB >> 21824611

Efficacy and safety of EMR to completely remove Barrett's esophagus: experience in 41 patients.

Henning Gerke1, Junaid Siddiqui, Issam Nasr, Daniel M Van Handel, Chris S Jensen.   

Abstract

BACKGROUND: EMR is typically used to remove focal abnormalities of the esophageal mucosa. However, larger areas of Barrett's esophagus (BE) can be resected through side-by-side resections.
OBJECTIVE: To assess the efficacy and safety of EMR to completely remove BE.
DESIGN: Retrospective, single-center study.
SETTING: University of Iowa Hospitals and Clinics. PATIENTS: Between January 2006 and December 2010, 46 patients underwent EMR for complete removal of BE. Three were lost to follow-up, one died of unrelated causes before completion, and one was still undergoing EMR treatment at the conclusion of the study. The remaining 41 patients were included for analysis. The worst histologic grade was low-grade dysplasia in 4 patients, high-grade dysplasia without cancer in 26 patients, and high-grade dysplasia with superficial adenocarcinoma in 11 patients. BE was circumferential in 65.9% of cases, and the mean (± SD) length was 3.3 ± 2.3 cm. INTERVENTION: EMR was performed by using a cap (n = 4), a multiband ligator device (n = 31), or both (n = 6), with a mean (± SD) of 2.4 ± 1.2 sessions per patient. MAIN OUTCOME MEASUREMENTS: Remission rates and complications.
RESULTS: Remission of high-grade dysplasia and cancer, all dysplasia, and all BE was achieved in 94.6%, 85.4%, and 78.0%, respectively. Complications included minor bleeding (31.7%), perforations (4.9%), and strictures (43.9%). All complications were managed conservatively. LIMITATIONS: Retrospective design.
CONCLUSION: Complete removal of BE with EMR is effective but associated with a high complication rate, which is mainly related to stricture formation. This needs to be considered when choosing between available treatment modalities.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21824611     DOI: 10.1016/j.gie.2011.06.009

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  11 in total

Review 1.  Endoscopic options for treatment of dysplasia in Barrett's esophagus.

Authors:  R Brooks Vance; Kerry B Dunbar
Journal:  World J Gastrointest Endosc       Date:  2015-12-25

Review 2.  Endoluminal therapies for Barrett's esophagus.

Authors:  Carmen L Mueller; Lorenzo E Ferri
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

Review 3.  Multiband mucosectomy for advanced dysplastic lesions in the upper digestive tract.

Authors:  Jesús Espinel; Eugenia Pinedo; Vanesa Ojeda; Maria Guerra Del Rio
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

Review 4.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

Review 5.  Risk of recurrence of Barrett's esophagus after successful endoscopic therapy.

Authors:  Rajesh Krishnamoorthi; Siddharth Singh; Karthik Ragunathan; David A Katzka; Kenneth K Wang; Prasad G Iyer
Journal:  Gastrointest Endosc       Date:  2016-02-20       Impact factor: 9.427

Review 6.  Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.

Authors:  George Sgourakis; Ines Gockel; Hauke Lang
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 7.  EMR is not inferior to ESD for early Barrett's and EGJ neoplasia: An extensive review on outcome, recurrence and complication rates.

Authors:  Yoriaki Komeda; Marco Bruno; Arjun Koch
Journal:  Endosc Int Open       Date:  2014-05-07

Review 8.  Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.

Authors:  Ajaypal Singh; Amitabh Chak
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-10-19

Review 9.  Endoscopic resection of gastric and esophageal cancer.

Authors:  Bryan Balmadrid; Joo Ha Hwang
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-10-27

10.  Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis.

Authors:  Larissa L Fujii-Lau; Birtukan Cinnor; Nicholas Shaheen; Srinivas Gaddam; Srinadh Komanduri; V Raman Muthusamy; Ananya Das; Robert Wilson; Violette C Simon; Vladimir Kushnir; Daniel Mullady; Steven A Edmundowicz; Dayna S Early; Sachin Wani
Journal:  Endosc Int Open       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.